|
|
Hepatitis
|
|
Definition of Hepatitis
An inflammation of the liver caused by a number of etiologic agents, including viruses, bacteria, fungi, parasites, drugs, and chemicals. The most common infectious hepatitis is of viral etiology.
|
Needlestick Injuries Common Among Surgery Students
American surgeons-in-training stick themselves far too often with needles that could carry infection, and they often fail to report that they've done so. That's the conclusion of a new study in the June 28 issue of the New England Journal of Medicine.
Read the Article
|
Hepatitis B Drug a Threat to Those With HIV
Patients infected with both hepatitis B and HIV should not take the hepatitis-fighting drug Baraclude on its own, new research confirms. The problem is that Baraclude (entecavir) can cause HIV to become resistant to life-extending AIDS medications, according to a study in the June 21 New England Journal of Medicine.
Read the Article
|
Study Suggests Cure for Hepatitis C
"This paper strongly suggests, for the first time, that hepatitis C is a curable disease," said lead researcher Dr. Mitchell Shiffman, a professor at Virginia Commonwealth University School of Medicine and chief of hepatology and medical director of the school's Liver Transplant Program. "After treatment, 99.6 percent of the patients remained virus undetectable for over five years," he added.
Read the Article
|
Hepatitis C Infection Hampers Liver Transplant Success
While survival rates have improved for liver transplant patients without hepatitis C (HCV), that's not the case for liver recipients infected with the virus, new research shows. HCV-induced liver disease is the most common reason for liver transplantation in the United States.
Read the Article
|
Hepatitis C Infection Ups Lymphoma Risk
People with the liver disease hepatitis C face a higher risk of developing lymphoma, a cancer of the immune system, new research suggests. Overall, the risk is almost 30 percent higher, but for a certain type of lymphoma called Waldenstrom's macroglobulinemia, the risk is almost 300 percent higher, according to the study.
Read the Article
|
Biologic Drug Approved to Prevent Hepatitis B in Liver Recipients
HepaGam B, a first-of-its-kind immune globulin product, has been approved by the U.S. Food and Drug Administration to prevent hepatitis B reinfection among people who have received liver transplants, the agency said Friday.
Read the Article
|
Raising a Glass for the World's Poor
On March 22, thirsty New York City diners will be helping poor children around the world with every gulp. Diners at 225 restaurants around the city will be asked to pay $1 for something that normally comes free: the water that arrives with their meal.
Read the Article
|
U.S. Hepatitis Rates Fall to New Lows
U.S. rates of infection with hepatitis A, B and C viruses have fallen to historic lows, reducing the threat of liver disease, according to a new federal report. Infection with these three most common forms of acute viral hepatitis have dropped dramatically between 1995 and 2005, the U.S. Centers for Disease Control and Prevention announced Thursday.
Read the Article
|
Hepatitis B Drug Triggers HIV Drug Resistance
A commonly used hepatitis drug spurs resistance to HIV drugs in patients who are infected with both viruses, Johns Hopkins researchers report. Although many medications have this problem, entecavir (Baraclude) was thought to be different.
Read the Article
|
Blood Test Index May Help Liver Patients Avoid Biopsy
A new index that involves simple blood tests might spare patients invasive biopsies used to diagnose liver fibrosis, Japanese researchers report. Fibrosis, the formation of scar-like tissue in the liver, indicates damage that can lead to cirrhosis. In people with hepatitis C, determining the stage of liver fibrosis is important for patient prognosis and treatment, according to background information in the article.
Read the Article
|
Heavy Drinking Exacts Toll on Women With Hepatitis C
Heavy drinking slashes the life spans of women with hepatitis C, a new study says. Publishing in the February issue of Alcoholism: Clinical and Experimental Research, the researchers noted that women with hepatitis C tend to live longer than men with the virus. However, this study found that heavy drinking eliminates that survival advantage in women.
Read the Article
|
Incidence of Steatosis in Hepatitis Patients Traced to Race
White hepatitis C patients are more likely to have a complication known as steatosis than black patients, says a new study. Hepatic steatosis, or fat in the liver, is a condition common among people with the hepatitis C virus. It indicates more advanced disease.
Read the Article
|
Earlier HIV Therapy Helps Beat Back Hepatitis C
Starting HIV antiretroviral therapy earlier than generally recommended may lead to better control of the hepatitis C virus in people also infected with HIV, a new study finds. Infection with both hepatitis C and HIV is a growing problem, say researchers at the Partners AIDS Research Center at Massachusetts General Hospital, Boston. While the immune systems of many people infected with the hepatitis C virus (HCV) are able to naturally control levels of that virus, this natural control may be lost in people who are also infected with HIV, the virus that causes AIDS.
Read the Article
|
Hepatitis A Vaccine Best Bet to Treat Virus
Treating the liver disease hepatitis A with the hepatitis A vaccine is as effective as treating it with the more traditional injection of immune globulin, a new study found. Based on these results, the U.S. Centers for Diseases Control and Prevention's Advisory Committee on Immunization Practices now recommends the vaccine as the preferred treatment for the hepatitis A virus, according to a report in the CDC's Oct. 19 issue of its Morbidity and Mortality Weekly Report.
Read the Article
|
|
Page: 1 2 3 4
Members currently browsing this category:
|
|
|
